High anti-tumor necrosis factor alpha treatment trough concentrations are not associated with higher rate of adverse events in pediatric patients with inflammatory bowel disease

被引：0
|
作者：
Zvuloni, M. [1 ]
Matar, M. [2 ]
Levi, R. [3 ]
Shamir, R. [1 ,2 ]
Assa, A. [2 ,4 ]
机构：
[1] Tel Aviv Univ, Sackler Fac Med, Dept Med, Tel Aviv, Israel
[2] Schneider Childrens Hosp, Inst Gastroenterol Nutr & Liver Dis, Petah Tiqwa, Israel
[3] Schneider Childrens Hosp, Pediat Dept A, Petah Tiqwa, Israel
[4] Ben Gurion Univ Negev, Dept Med, Beer Sheva, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.506
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P382
引用
收藏
页码：S395 / S395
页数：1
相关论文
共 50 条
  • [1] Neurological adverse events associated with anti-tumor necrosis factor alpha treatment
    Tristano, Antonio G.
    JOURNAL OF NEUROLOGY, 2010, 257 (09) : 1421 - 1431
  • [2] Neurological adverse events associated with anti-tumor necrosis factor alpha treatment
    Antonio G. Tristano
    Journal of Neurology, 2010, 257 : 1421 - 1431
  • [3] Neurological Adverse Effects Associated With Anti-tumor Necrosis Factor Alpha Antibodies in Pediatric Inflammatory Bowel Diseases
    Bertrand, Valerie
    Massy, Nathalie
    Pigneur, Benedicte
    Coopman, Stephanie
    Durrieu, Genevieve
    Gaboriau, Louise
    Langlois, Vincent
    Gower-Rousseau, Corinne
    Hugot, Jean-Pierre
    Ruemmele, Frank M.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 70 (06): : 841 - 848
  • [4] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Lew, Daniel
    Yoon, Soon Man
    Yan, Xiaofei
    Robbins, Lori
    Haritunians, Talin
    Liu, Zhenqiu
    Li, Dalin
    McGovern, Dermot P. B.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (40) : 7265 - 7273
  • [5] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Daniel Lew
    Soon Man Yoon
    Xiaofei Yan
    Lori Robbins
    Talin Haritunians
    Zhenqiu Liu
    Dalin Li
    Dermot PB McGovern
    World Journal of Gastroenterology, 2017, (40) : 7265 - 7273
  • [6] Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease
    Kim, Ju Young
    Lee, Yoon
    Choe, Byung-Ho
    Kang, Ben
    GUT AND LIVER, 2021, 15 (04) : 588 - 598
  • [7] Pediatric inflammatory bowel disease: Fecal calprotectin response to Anti-tumor necrosis factor alpha
    Matar, Manar
    Levi, Rachel
    Zvuloni, Maya
    Shamir, Raanan
    Assa, Amit
    PEDIATRIC RESEARCH, 2023, 93 (01) : 131 - 136
  • [8] Pediatric inflammatory bowel disease: Fecal calprotectin response to Anti-tumor necrosis factor alpha
    Manar Matar
    Rachel Levi
    Maya Zvuloni
    Raanan Shamir
    Amit Assa
    Pediatric Research, 2023, 93 : 131 - 136
  • [9] Anti-Tumor Necrosis Factor Treatment of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Jegadeesan, Ramprasad
    Kochhar, Gursimran
    Hayat, Umar
    Kim, Ahyoung J.
    Lan, Nan
    Sanaka, Madhusudhan R.
    Shen, Bo
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2016, 150 (04) : S396 - S397
  • [10] Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents
    Eickstaedt, Joshua B.
    Killpack, Luke
    Tung, Jeanne
    Davis, Dawn
    Hand, Jennifer L.
    Tollefson, Megha M.
    PEDIATRIC DERMATOLOGY, 2017, 34 (03) : 253 - 260
12345